Cargando…
A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin
BACKGROUND: Severe hypercholesterolemia (HC, LDL‐C > 4.9 mmol/L) affects over 30 million people worldwide. In this study, we validated a new polygenic risk score (PRS) for LDL‐C. METHODS: Summary statistics from the Global Lipid Genome Consortium and genotype data from two large populations were...
Autores principales: | Leal, Luis G., Hoggart, Clive, Jarvelin, Marjo‐Riitta, Herzig, Karl‐Heinz, Sternberg, Michael J. E., David, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284038/ https://www.ncbi.nlm.nih.gov/pubmed/32307928 http://dx.doi.org/10.1002/mgg3.1248 |
Ejemplares similares
-
Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019) -
Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019) -
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022) -
Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022) -
Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)